fashion -WSS

fashion

author：explore 2025-10-01 18:23:57 - browse：38181

Chief executive officer of Sanofi Paul Hudson, wearing glasses, speaks into a mic — pharma coverage from STAT — Sanofi CEO Paul Hudson Carolyn Kaster/AP

LONDON — Sanofi CEO Paul Hudson on Wednesday defended his company’s recent moves to abandon future profit guidance and up its investment in its own research programs, arguing that the dramatically negative market response didn’t reflect the potential rewards that could stem from the plan.

“Would I have liked the stock market reaction to be more generous? Of course,” Hudson said at a Financial Times event in London. “But this is a long-term game, and if you’re trying to deliver long-term value, you try not to make too many short-term decisions.”

Sanofi unveiled its R&D plans late last month as it announced its third-quarter performance and said that it was spinning out its consumer health division. As the company said it was going to spend more money on research, it also withdrew earnings outlooks for 2025. Company executives have argued that this was the moment — when Sanofi has a strong pipeline and isn’t facing patent expirations for years — to increase its R&D resources, even at the expense of short-term profits.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Brain 'hot spot' may explain why African Americans feel greater pain

WSS

Why psychiatrists like me stop taking insurance

GSK Flovent asthma inhalers replaced by authorized generics

Morgan Health, with ambitious aims, wants you to know it’s still here

GSK Flovent asthma inhalers replaced by authorized generics

Burning questions for the 2024 JPM Healthcare Conference

Meta looks to target Twitter with a rival app called Threads

knowledge

fashion

leisure time

Medicare details structure of new drug price negotiation program

Inside the fall of star MIT scientist David Sabatini

Walensky prepares to leave CDC — and Congress — behind

Did the public have the right to know Arthur Ashe had AIDS?

United colonoscopy coverage change 'may cost lives,' doctors say

4th of July breaks record for highest global temperature ever measured

The high cost of giving birth even with insurance

Connecting traumatic brain injury and domestic violence

Apple is now the first public company to be valued at $3 trillion

7 people shot in DC, police say

hotspot

3 trends to watch in health tech's hiring outlook for 2024

A new study asks: Are we harming blood donors by taking blood?

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

When is a doctor not a doctor? Try when patients address women doctors

Option Care buys Amedisys in $3.6 billion home care deal

The FDA must approve intranasal treatments for anaphylaxis

focus

knowledge

hotspot

hotspot